239 related articles for article (PubMed ID: 29985945)
1. Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling.
Zhang B; Alruwaili N; Kandhi S; Deng W; Huang A; Wolin MS; Sun D
PLoS One; 2018; 13(7):e0200307. PubMed ID: 29985945
[TBL] [Abstract][Full Text] [Related]
2. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats.
Priviero FB; Zemse SM; Teixeira CE; Webb RC
Am J Hypertens; 2009 May; 22(5):493-9. PubMed ID: 19247264
[TBL] [Abstract][Full Text] [Related]
4. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
5. Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxation.
Yetik-Anacak G; Xia T; Dimitropoulou C; Venema RC; Catravas JD
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H260-8. PubMed ID: 16489110
[TBL] [Abstract][Full Text] [Related]
6. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
[TBL] [Abstract][Full Text] [Related]
7. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
[TBL] [Abstract][Full Text] [Related]
8. Restoration of impaired endothelium-dependent coronary vasodilation in failing heart: role of eNOS phosphorylation and CGMP/cGK-I signaling.
Gill RM; Braz JC; Jin N; Etgen GJ; Shen W
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2782-90. PubMed ID: 17322419
[TBL] [Abstract][Full Text] [Related]
9. Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway.
Xia T; Guan W; Fu J; Zou X; Han Y; Chen C; Zhou L; Zeng C; Wang WE
Biochem Biophys Res Commun; 2016 Jun; 474(3):599-605. PubMed ID: 27018249
[TBL] [Abstract][Full Text] [Related]
10. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
[TBL] [Abstract][Full Text] [Related]
11. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells.
Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y
Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439
[TBL] [Abstract][Full Text] [Related]
12. Age Impairs Soluble Guanylyl Cyclase Function in Mouse Mesenteric Arteries.
Zhong C; Xu M; Boral S; Summer H; Lichtenberger FB; Erdoğan C; Gollasch M; Golz S; Persson PB; Schleifenbaum J; Patzak A; Khedkar PH
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768842
[TBL] [Abstract][Full Text] [Related]
13. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
[TBL] [Abstract][Full Text] [Related]
14. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase.
Brandes RP; Kim D; Schmitz-Winnenthal FH; Amidi M; Gödecke A; Mülsch A; Busse R
Hypertension; 2000 Jan; 35(1 Pt 2):231-6. PubMed ID: 10642303
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Activation and Stabilization of Soluble Guanylate Cyclase by the Protoporphyrin IX Mimetic Cinaciguat.
Kollau A; Opelt M; Wölkart G; Gorren ACF; Russwurm M; Koesling D; Mayer B; Schrammel A
Mol Pharmacol; 2018 Feb; 93(2):73-78. PubMed ID: 29138269
[TBL] [Abstract][Full Text] [Related]
16. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 depletion of cartilage oligomeric matrix protein modulates pulmonary artery superoxide and iron metabolism-associated mitochondrial heme biosynthesis.
Yu H; Alruwaili N; Kelly MR; Zhang B; Liu A; Wang Y; Sun D; Wolin MS
Am J Physiol Lung Cell Mol Physiol; 2022 Oct; 323(4):L400-L409. PubMed ID: 35943724
[TBL] [Abstract][Full Text] [Related]
18. Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?
Neves KB; Lobato NS; Lopes RA; Filgueira FP; Zanotto CZ; Oliveira AM; Tostes RC
Clin Sci (Lond); 2014 Jul; 127(2):111-22. PubMed ID: 24498891
[TBL] [Abstract][Full Text] [Related]
19. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
Dai Y; Stuehr DJ
Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790
[TBL] [Abstract][Full Text] [Related]
20. Hydrogen sulfide dysfunction in metabolic syndrome-associated vascular complications involves cGMP regulation through soluble guanylyl cyclase persulfidation.
Smimmo M; Casale V; Casillo GM; Mitidieri E; d'Emmanuele di Villa Bianca R; Bello I; Schettino A; Montanaro R; Brancaleone V; Indolfi C; Cirino G; Di Lorenzo A; Bucci M; Panza E; Vellecco V
Biomed Pharmacother; 2024 May; 174():116466. PubMed ID: 38552439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
